Multidisciplinary Team in Management of Placenta Accreta

December 9, 2017 updated by: sarah mohamed hassan, Kasr El Aini Hospital

is There Any Superior Benefit of Multidisciplinary Team in Management of Placenta Accreta

comparative study between the incidence of urological injury in case of placenta accreta in cases where urological surgical staff are participating in the operation from the start and in cases where the operation is carried by the gynecological staff only

Study Overview

Status

Unknown

Conditions

Detailed Description

cohort of 1000 patients of placenta accreta are followed regarding the incidence of urological injury in the cases with assistance from the urological staff members

Study Type

Observational

Enrollment (Anticipated)

1000

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Cairo, Egypt, 11562
        • Kasr El Ainiy Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

20 years to 40 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Female

Sampling Method

Probability Sample

Study Population

1000 patients pregnant 38 weeks with placenta accreta

Description

Inclusion Criteria:

  • pregnant 38 weeks
  • placenta accreta

Exclusion Criteria:

  • medical disorders complicating pregnancy

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
multidisciplinary team group
500 patients of placenta accreta managed by obstetricans and urologists
upper segment cesarean section and or cesarean hysteroctomy
obstetricians only group
500 patients of placenta accreta managed by obstetricans only
upper segment cesarean section and or cesarean hysteroctomy

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
urological injury
Time Frame: intraoperative
badder or ureteric injury
intraoperative

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Anticipated)

December 1, 2017

Primary Completion (Anticipated)

March 1, 2018

Study Completion (Anticipated)

March 1, 2018

Study Registration Dates

First Submitted

December 9, 2017

First Submitted That Met QC Criteria

December 9, 2017

First Posted (Actual)

December 13, 2017

Study Record Updates

Last Update Posted (Actual)

December 13, 2017

Last Update Submitted That Met QC Criteria

December 9, 2017

Last Verified

December 1, 2017

More Information

Terms related to this study

Keywords

Other Study ID Numbers

  • 494608

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Placenta Accreta

Clinical Trials on cesarean section or cesarean hysterectomy

3
Subscribe